Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
Clinical trial NCT03576287 · UNKNOWN
Trial details
- NCT number
- NCT03576287
- Sponsor
- Tanja Todberg, MD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.